Table 7 Haplotype analysis for genotypes of mTOR and ESCC risk
Haplotype frequencies | ||||||||
---|---|---|---|---|---|---|---|---|
Cases (N = 2232) | Controls (N = 2234) | |||||||
Haplotypes a | n | % | n | % | Crude OR (95% CI) | P | Adjusted OR (95% CI) | P a |
T-T-A | 1700 | 76.23 | 1746 | 78.72 | 1.00 | 0.009 | 1.00 | |
T-C-A | 23 | 1.03 | 9 | 0.41 | 2.63 (1.21–5.69) | 0.015 | 2.96 (1.32–6.67 | 0.023 |
T-C-G | 19 | 0.85 | 6 | 0.27 | 3.25 (1.30–8.16) | 0.012 | 2.97 (1.16–7.60) | 0.024 |
G-T-A | 40 | 1.79 | 18 | 0.81 | 2.28 (1.30–4.00) | 0.004 | 2.41 (1.34–4.37) | 0.003 |
G-T-G | 33 | 1.48 | 27 | 1.22 | 1.26 (0.75–2.10) | 0.385 | 1.38 (0.81–2.35) | 0.234 |
T-C-G | 265 | 11.88 | 271 | 12.22 | 1.01 (0.84–1.21) | 0.963 | 1.03 (0.85–1.24) | 0.795 |
G-T-A | 150 | 6.73 | 141 | 6.36 | 1.09 (0.86–1.39) | 0.468 | 1.12 (0.87–1.43) | 0.380 |